SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905148-22-000284
Filing Date
2022-02-14
Accepted
2022-02-14 16:21:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc22-175_sc13g.htm SC 13G 124150
  Complete submission text file 0000905148-22-000284.txt   125993
Mailing Address 610 BROADWAY 6TH FLOOR NEW YORK NY 10012
Business Address 610 BROADWAY 6TH FLOOR NEW YORK NY 10012 212-610-9077
Anchorage Capital Group, L.L.C. (Filed by) CIK: 0001300714 (see all company filings)

IRS No.: 200042271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Subject) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92710 | Film No.: 22632481
SIC: 2836 Biological Products, (No Diagnostic Substances)